Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2025 16:50 ET | Source: Larkspur Biosciences, Inc.

Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting

Larkspur Biosciences Announces Discovery of LRK-4189, 1st-in-Class Degrader of Lipid Kinase PIP4K2C, for Treatment of MSS CRC at ACS Fall 2025 Meeting